U.S. pharma big copyright scrapped two experimental weight loss products last yr—a the moment-every day pill, lotiglipron, on account of elevated liver enzymes and a twice-day-to-day pill, danuglipron, as a result of potent Uncomfortable side effects—but CEO Albert Bourla has stated the company is determined to “play and get” from the weigh